<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01834144</url>
  </required_header>
  <id_info>
    <org_study_id>B2012:136</org_study_id>
    <nct_id>NCT01834144</nct_id>
  </id_info>
  <brief_title>The VIGORous Physical Activity for Glycaemic Control in Type 1 Diabetes (VIGOR) Trial</brief_title>
  <acronym>VIGOR</acronym>
  <official_title>The VIGORous Physical Activity for Glycaemic Control in Type 1 Diabetes (VIGOR) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Manitoba Institute of Child Health</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background/Justification: Regular physical activity (PA) has substantial health benefits in
      persons with type 1 diabetes (T1D), including reduced risk of complications and
      cardiovascular mortality. Despite these benefits, individuals with T1D remain significantly
      less active than their peers without diabetes. Two major factors likely explain the low rates
      of PA in young people with T1D: (1) fear of post-exercise hypoglycaemia, particularly
      nocturnal hypoglycaemia, and (2) a lack of empirical evidence for the efficacy of PA for
      achieving optimal glycaemic control. A number of acute exercise trials recently demonstrated
      that the inclusion of vigorous intensity PA in conventional moderate intensity (i.e. walking)
      PA sessions may overcome these limitations. No studies have tested the efficacy of high
      intensity PA for reducing the risk of exercise-related hypoglycaemia or glycaemic variability
      in a randomized controlled trial (RCT).

      Study Hypotheses: In persons 15-35 years of age living with T1D, this study will test the
      hypotheses that (1) the addition of intermittent vigorous intensity PA to a moderate
      intensity intervention will reduce the time spent in hypoglycaemia in the 12 hour period
      following exercise and (2) the addition of intermittent vigorous intensity PA to a moderate
      intensity PA intervention will elicit significant improvements in glycemic excursions, as
      measured by the Mean Amplitude of Glycaemic Excursions (MAGE), in the 12-hour period
      following exercise.We are also exploring the hypothesis that reducing the risk of
      hypoglycemia will lead to a sustained increase in physical activity one year after
      randomization.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Funding for the study was not renewed
  </why_stopped>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">June 15, 2015</completion_date>
  <primary_completion_date type="Actual">June 15, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Spent in Hypoglycaemia in the 12-hour Period Following Exercise, Defined as an Interstitial Glucose Reading &lt;4.0mmol/L and Measured by Continuous Glucose Monitor.</measure>
    <time_frame>Measured at baseline, and 1, 8,16 and 52 weeks following randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycaemic Variability, Measured by the Mean Amplitude of Glycaemic Excursions (MAGE), in the 12-hour Period Following Exercise. This is Calculated From the Same Continuous Glucose Monitor Data as the Primary Outcome.</measure>
    <time_frame>Measured at baseline, and 1, 8, 16 and 52 weeks following randomization</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Moderate intensity exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>150-200 minutes of weekly moderate intensity exercise (45-55% of peak fitness)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate + Vigorous Intensity Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>150-200 minutes of weekly moderate intensity exercise, with short bouts of vigorous intensity exercise (80-90% of peak fitness)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise Training</intervention_name>
    <arm_group_label>Moderate + Vigorous Intensity Exercise</arm_group_label>
    <arm_group_label>Moderate intensity exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 15-45 years old

          -  Have lived with type 1 diabetes for at least 2 years

          -  HbA1c &lt;9.9%

          -  Currently physically inactive (&lt;150 minutes of self-reported structured physical
             activity per week)

          -  Undergone a resting ECG to screen for left ventricular hypertrophy, arrhythmias or
             signs or coronary artery disease that may be exacerbated with vigorous intensity
             exercise

        Exclusion Criteria:

          -  Have frequent and unpredictable hypoglycaemia

          -  Had a change in insulin management strategy, including adoption of a pump, within 2
             months of enrolment

          -  Are currently participating in structured activity or sport-related activities

          -  Are women who are pregnant or planning to get pregnant within the 12 months of the
             trial and those who are breastfeeding

          -  Have conditions that would render physical activity contraindicated including:
             uncontrolled hypertension (BP&gt;150mmHg systolic or &gt;95mmHg diastolic in a sitting
             position); severe peripheral neuropathy; history of cardiovascular disease

          -  Have a cognitive deficit resulting in an inability to provide informed consent

          -  Currently taking beta blockers

          -  Currently taking atypical antipsychotics or corticosteroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 1N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2R3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manitoba Institute of Child Health</name>
      <address>
        <city>WInnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 3P4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 4L8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Ottawa</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1N 6N5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>March 27, 2013</study_first_submitted>
  <study_first_submitted_qc>April 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2013</study_first_posted>
  <results_first_submitted>January 16, 2018</results_first_submitted>
  <results_first_submitted_qc>January 16, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 20, 2018</results_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manitoba</investigator_affiliation>
    <investigator_full_name>Jon McGavock</investigator_full_name>
    <investigator_title>Associate Professor, Dept. Of Pediatrics and Child Health</investigator_title>
  </responsible_party>
  <keyword>Type 1 Diabetes</keyword>
  <keyword>Hypoglycaemia</keyword>
  <keyword>Glycaemic variability</keyword>
  <keyword>Vigorous Intensity Physical Activity</keyword>
  <keyword>Continuous Glucose Monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Moderate Intensity Exercise</title>
          <description>150-200 minutes of weekly moderate intensity exercise (45-55% of peak fitness)
Exercise Training</description>
        </group>
        <group group_id="P2">
          <title>Moderate + Vigorous Intensity Exercise</title>
          <description>150-200 minutes of weekly moderate intensity exercise, with short bouts of vigorous intensity exercise (80-90% of peak fitness)
Exercise Training</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Moderate Intensity Exercise</title>
          <description>150-200 minutes of weekly moderate intensity exercise (45-55% of peak fitness)
Exercise Training</description>
        </group>
        <group group_id="B2">
          <title>Moderate + Vigorous Intensity Exercise</title>
          <description>150-200 minutes of weekly moderate intensity exercise, with short bouts of vigorous intensity exercise (80-90% of peak fitness)
Exercise Training</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="4"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0" spread="0"/>
                    <measurement group_id="B2" value="0" spread="0"/>
                    <measurement group_id="B3" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Study funding not renewed; do data analyzed</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time Spent in Hypoglycaemia in the 12-hour Period Following Exercise, Defined as an Interstitial Glucose Reading &lt;4.0mmol/L and Measured by Continuous Glucose Monitor.</title>
        <time_frame>Measured at baseline, and 1, 8,16 and 52 weeks following randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Moderate Intensity Exercise</title>
            <description>150-200 minutes of weekly moderate intensity exercise (45-55% of peak fitness)
Exercise Training</description>
          </group>
          <group group_id="O2">
            <title>Moderate + Vigorous Intensity Exercise</title>
            <description>150-200 minutes of weekly moderate intensity exercise, with short bouts of vigorous intensity exercise (80-90% of peak fitness)
Exercise Training</description>
          </group>
        </group_list>
        <measure>
          <title>Time Spent in Hypoglycaemia in the 12-hour Period Following Exercise, Defined as an Interstitial Glucose Reading &lt;4.0mmol/L and Measured by Continuous Glucose Monitor.</title>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glycaemic Variability, Measured by the Mean Amplitude of Glycaemic Excursions (MAGE), in the 12-hour Period Following Exercise. This is Calculated From the Same Continuous Glucose Monitor Data as the Primary Outcome.</title>
        <time_frame>Measured at baseline, and 1, 8, 16 and 52 weeks following randomization</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Moderate Intensity Exercise</title>
          <description>150-200 minutes of weekly moderate intensity exercise (45-55% of peak fitness)
Exercise Training</description>
        </group>
        <group group_id="E2">
          <title>Moderate + Vigorous Intensity Exercise</title>
          <description>150-200 minutes of weekly moderate intensity exercise, with short bouts of vigorous intensity exercise (80-90% of peak fitness)
Exercise Training</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jonathan McGavock</name_or_title>
      <organization>University of Manitoba</organization>
      <phone>204-480-1359</phone>
      <email>jmcgavock@chrim.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

